newsfilter
← Latest News
ClinicalTrials.gov·

A Phase 2b Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) - NCT05781750

To evaluate the efficacy of zetomipzomib, To evaluate safety of zetomipzomib, Partial Renal Remission (PRR), CRR